EuroSIDA Publications 2016

1 Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study
. A Mocroft, JD Lundgren, M Ross, CA Fux  P Reiss, O Moranne, P Morlat, A d'Arminio Monforte, O Kirk, L Ryom, on behalf of The Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study. 
Lancet HIV. 2016 Jan;3(1):e23-32. doi: 10.1016/S2352-3018(15)00211-8.  abstract

2 Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis. Antiretroviral Therapy Cohort Collaboration (ART-CC); Canadian Observational Cohort Collaboration (CANOC); UK Collaborative HIV Cohort Study (UK CHIC); Collaboration of Observational HIV Epidemiological Research in Europe (COHERE).
AIDS. 2016 Jan 28;30(3):503-13. abstract

3 Tuberculosis-related mortality in people living with HIV In Europe and Latin America: an international cohort study. Daria Podlekareva, Anne Marie W. Efsen, Anna Schultze, Frank Post,, Alena M. Skrahina, Alexander Panteleev, Hansjakob Furrer, Robert F. Miller, Marcelo H. Losso, Javier Toibaro, Jose M. Miro, Anna Vassilenko, Enrico Girardi, Mathias Bruyans, Niels Obel, Jens D. Lundgren, Amanda Mocroft, Ole kirk on behalf of the TB:HIV study group in EuroCoord. 
Lancet HIV. 2016 Mar;3(3):e120-31. doi: 10.1016/S2352-3018(15)00252-0. Epub 2016 Feb 2. abstract

4 Antiretroviral drugs and risk of chronic ALT elevation in HIV-infected persons without viral hepatitis coinfection. The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study H Kovari, CA Sabin, B Ledergerber, L Ryom, P Reiss, M Law, C Pradier, F Dabis, A d’Arminio Monforte, C Smith, S de Wit, O Kirk, JD Lundgren, R Weber , on behalf of the D:A:D Study group. 
Open Forum Infect Dis. 2016 Jan 21;3(1):ofw009. doi: 10.1093/ofid/ofw009. eCollection 2016. abstract

5 Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with human immunodeficiency virus (HIV)? A cohort collaboration. CA Sabin; P Reiss; L Ryom; AN Phillips, PhD; R Weber; M Law; E Fontas; A Mocroft; S de Wit; C Smith; F Dabis; A d'Arminio Monforte; W El-Sadr; JD Lundgren for the DAD Study Group.
BMC Med. 2016 Mar 31;14(1):61. abstract

6 An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons. N Friis-Møller, L Ryom, C Smith, R Weber, P Reiss, F Dabis, S De Wit, A D’Arminio Monforte, O Kirk, E Fontas, C Sabin, A Phillips, J Lundgren, M Law, on behalf of the D:A:D study group.
Eur J Prev Cardiol. 2016 Jan;23(2):214-23. abstract

7 Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study. Amit C Achhra; Amanda Mocroft; Peter Reiss; Caroline Sabin; Lene Ryom; Stephane de Wit; Colette J Smith; Antonella d´arminio Monforte; Andrew Phillips; Rainer Weber;  Jens Lundgren;  Matthew G Law; The D:A:D Study Group. 
HIV Med. 2016 Apr;17(4):255-68. abstract

8 Is Nelfinavir Exposure Associated with Cancer Incidence in HIV-positive individuals? DC Boettiger, CA Sabin, A Grulich, L Ryom, F Bonnet, P Reiss, A d’ArminioMonforte, O Kirk, A Phillips,  M Bower, G Fätkenheuer, JD Lundgren, M Law on behalf of the Data collection on Adverse events of Anti-HIV Drugs (D:A:D) study group
AIDS. 2016 Jun 19;30(10):1629-37. abstract

9 Improvements over time in short-term mortality following myocardial infarction in HIV-positive individuals. CI Hatleberg, L Ryom, W El-Sadr, C Smith, R Weber, P Reiss, E Fontas,  F Dabis, M Law,  A d’Arminio Monforte,  Stephane De Wit,  A Mocroft,  A Phillips,  J D. Lundgren and C Sabin for the D:A:D Study Group
AIDS. 2016 Jun 19;30(10):1583-96. abstract

10 Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons. L Ryom, JD Lundgren, S De Wit, H Kovari, P Reiss, M Law, W El-Sadr, A D’Arminio Monforte, Amanda Mocroft, C Smith, E Fontas, F Dabis, A Phillips and C Sabin for the D:A:D Study Group.
AIDS. 2016 Jul 17;30(11):1731-43. abstract

11 Associations between HIV-RNA-based indicators and virological and clinical outcomes. K Laut, L Shepherd, C Pedersen, JK Rockstroh, H Sambatakou, D Paduta, R Matulionyte, T Smiatacz, F Mulcahy, JD Lundgren, A Mocroft, O Kirk, on behalf of EuroSIDA in EuroCoord. 
AIDS 2016 Jul 31;30(12):1961-72. abstract

12 Disparities in HIV clinic care across Europe: findings from the EuroSIDA clinic survey.  JV Lazarus, K Laut, K Safreed-Harmon, L Peters, M Johnson, G Fätkenheuer, I Khromova, L Vandekerckhove, K Maciejewska, R Radoi, AL Ridolfo, A Mocroft, on behalf of EuroSIDA in EuroCoord. 
BMC Infect Dis. 2016 Jul 20;16:335article

13 Infection-related and -unrelated malignancies, HIV and the aging population. Shepherd L, Borges Á, Ledergerber B, Domingo P, Castagna A, Rockstroh J, Knysz B, Tomazic J, Karpov I, Kirk O, Lundgren J, Mocroft A, on behalf of EuroSIDA in EuroCoord. 
HIV Med. 2016 Sep;17(8):590-600. doi: 10.1111/hiv.12359. Epub 2016 Feb 18. abstract

14 Renal Impairment and Cardiovascular Disease in HIV-positive Individuals; The D:A:D Study. L Ryom, JD  Lundgren, M Ross, O  Kirk, M  Law, P Morlat, C Smit, E Fontas, CA  Fux, CI  Hatleberg, S de Wit, CA Sabin and A Mocroft for the D:A:D Study Group
J Infect Dis. 2016 Oct 15;214(8):1212-20. abstract

15 Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study. Gjærde LI, Shepherd L Jablonowska E, Lazzarin A, Rougemont M, Darling K, Battegay M, Braun D, Martel-Laferriere V, Lundgren JD, Rockstroh JK, Gill J, Rauch A, Mocroft A, Klein MB, Peters L.
Clin Infect Dis. 2016 Sep 15;63(6):821-9. abstract

16 Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy. Trickey A, May MT, Vehreschild J, Obel N, Gill MJ, Crane H, Boesecke C, Samji H, Grabar S, Cazanave C, Cavassini M, Shepherd L, d'Arminio Monforte A, Smit C, Saag M, Lampe F, Hernando V, Montero M, Zangerle R, Justice AC, Sterling T, Miro J, Ingle S, Sterne J; Antiretroviral Therapy Cohort Collaboration (ART-CC).
PLoS One. 2016 Aug 15;11(8):e0160460. abstract

17 Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: a prospective cohort study JM Llibre, A Cozzi-Lepri, C Pedersen, M Ristola, M Losso, A Mocroft, V Mitsura, K Falconer, F Maltez, M Beniowski, V Vullo, G Hassoun, E Kuzovatova, J Szlavik, A Kuznetsova, H-J Stellbrink, C Duvivier, S Edwards, K Laut, R Paredes for the EuroSIDA Study Group.
Medicine: Volume 95(40), October 2016, p e5020. article abstract

18 The cardiovascular risk management for people living with HIV in Europe: how well are we doing? M Shahmanesh, A Schultze, F Burns, O Kirk, J Lundgren, C Mussini, C Pedersen, S De Wit, G Kutsyna, A Mocroft on behalf of EuroSIDA in EuroCoord. 
AIDS. 2016 Oct 23;30(16):2505-2518. abstract

19 Changing incidence and risk factors for Kaposi sarcoma by time since starting antiretroviral therapy: Collaborative analysis of 21 European cohort studies. The Cancer Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord. 
Clin Infect Dis. 2016 Nov 15;63(10):1373-1379. Epub 2016 Aug 17. abstract

20 Predictive value of prostate specific antigen in a European HIV-positive cohort: Does one size fit all? Leah Shepherd, Álvaro H. Borges, Lene Ravn, Richard Harvey, Mark Bower, Andrew Grulich, Michael Silverberg, Gitte Kronborg, Massimo Galli, Ole Kirk, Jens Lundgren, Amanda Mocroft on behalf of EuroSIDA in EuroCoord.
Antivir Ther. 2016;21(6):529-534. doi: 10.3851/IMP3026.  abstract

21 Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D study. DA Kamara, CA Sabin, L Ryom, P Reiss, M Rickenbach, CJ Smith, A Phillips, A Mocroft, S De Wit, M Law, A d’Arminio Monforte, F Dabis, C Pradier, JD  Lundgren.
Antivir Ther. 2016;21(6):495-506. doi: 10.3851/IMP3051. Epub 2016 Apr 26. abstract

Total Publications December
 2016: 252